Insights Hub.
Is the Move from “Black Box” to “Glass Box” Enough?
Price transparency will move traditional PBMs towards a glass box approach – but will that alone deliver the value consumers seek?
In the News
Lessons from COVID: Health care transformation starts when employers demand value
It’s time to challenge the idea that the only way to reduce costs is to give up services or access.
Real health care transformation will only happen when those who purchase health care benefits—employers—start demanding more value from their investments.
Why Benefits Managers Need to Explore “Value”
In this article for BenefitsPRO, our CEO Karthik Ganesh talks about an approach to health benefits that focuses on what really matters: employees’ physical, mental, and financial well-being.
Healthcare Rounds Podcast: Dissecting the PBM Model with Karthik Ganesh
“When you break it all down, value is really about alignment.” Our CEO, Karthik Ganesh, talks about why healthcare shouldn’t operate as a retail model and what value in healthcare truly means.
Blog
Value Xchange: Two Hours To Help You Better Meet The Moment
We’re bringing together a cadre of industry visionaries on April 20 for Value Xchange, our two-hour inaugural thought-leadership virtual event. Find out more about it in this Q&A with our CEO Karthik Ganesh.
Employers pick up 82% of the tab and are on the sidelines of value-based healthcare.
Employers bear an oversized burden regarding medical costs in the United States, and they’re often forced into suboptimal choices when doing so. A value-based approach to healthcare could change all that.
Is the Move from “Black Box” to “Glass Box” Enough?
Price transparency will move traditional PBMs towards a glass box approach – but will that alone deliver the value consumers seek?
Dissecting the PBM Model
“When you break it all down, value is really about alignment.” Our CEO Karthik Ganesh shares his thoughts on how PBMs should serve their members on Darwin Research Group’s Healthcare Rounds Podcast.
EmpiRx Health is really successful at getting conversion from those higher-cost drugs that a doctor might know about to a lower-cost drug with equal outcomes and efficacy.
Director of Pharmacy Solutions, Advisor
